The symptoms in this patient were relieved postoperatively.

CEA is a biomarker commonly used in colorectal cancer, however its use as a prognostic value is still controversial. Recent studies demonstrate that CEA produced locally by tumor cells has a higher prognostic value compared to serum CEA. It is intended to determine whether there is an…[Read more]